Zobrazeno 1 - 10
of 228
pro vyhledávání: '"Harel, BT"'
Autor:
Cano CA; Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Harel BT; Neuroscience Therapeutic Area Unit, Takeda Development Center Americas Inc., Cambridge, MA, USA., Scammell TE; Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Publikováno v:
Sleep [Sleep] 2024 Sep 09; Vol. 47 (9).
Autor:
Harel BT; Neuroscience Therapeutic Area Unit, Takeda Development Center Americas, Inc., Cambridge, MA, USA., Gattuso JJ; Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, Australia., Latzman RD; Neuroscience Therapeutic Area Unit, Takeda Development Center Americas, Inc., Cambridge, MA, USA., Maruff P; Cogstate Ltd, Melbourne, VIC, Australia., Scammell TE; Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Plazzi G; IRCCS-Institute of Neurological Sciences, Bologna, Italy.; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Publikováno v:
Sleep advances : a journal of the Sleep Research Society [Sleep Adv] 2024 Jun 26; Vol. 5 (1), pp. zpae043. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).
Publikováno v:
International Journal of General Medicine, Vol Volume 10, Pp 281-289 (2017)
Nicola A Cook,1 Jin Un Kim,1 Yasmin Pasha,1 Mary ME Crossey,1 Adrian J Schembri,2,3 Brian T Harel,2,4 Torben Kimhofer,5 Simon D Taylor-Robinson1 1Liver Unit, Division of Digestive Health, Department of Surgery and Cancer, Imperial College London, Lon
Externí odkaz:
https://doaj.org/article/d9e88f5368c543689d89f1a7565839c6
Autor:
Mahedy L; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK., Anderson EL; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK., Tilling K; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.; NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston, NHS Foundation Trust and University of Bristol, Bristol, BS8 2BN, UK., Thornton ZA; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK., Elmore AR; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.; NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston, NHS Foundation Trust and University of Bristol, Bristol, BS8 2BN, UK., Szalma S; Takeda Development Center Americas, Inc., San Diego, CA, USA., Simen A; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Culp M; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Zicha S; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Harel BT; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Davey Smith G; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.; NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston, NHS Foundation Trust and University of Bristol, Bristol, BS8 2BN, UK., Smith EN; Takeda Development Center Americas, Inc., San Diego, CA, USA., Paternoster L; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, BS8 2BN, UK. lavinia.paternoster@bristol.ac.uk.; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK. lavinia.paternoster@bristol.ac.uk.; NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston, NHS Foundation Trust and University of Bristol, Bristol, BS8 2BN, UK. lavinia.paternoster@bristol.ac.uk.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2024 Jan 18; Vol. 14 (1), pp. 31. Date of Electronic Publication: 2024 Jan 18.
Background: Psychometric testing is used to identify patients with cirrhosis who have developed hepatic encephalopathy (HE). Most batteries consist of a series of paper-and-pencil tests, which are cumbersome for most clinicians. A modern, easy-to-use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::660168842079acae2ee8c243670481e2
http://hdl.handle.net/10044/1/50088
http://hdl.handle.net/10044/1/50088
Autor:
Heitzer AM; Department of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA., Ashford JM; Department of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA., Harel BT; Takeda Pharmaceuticals International Co, Cambridge, MA, USA., Schembri A; Cogstate Limited, New Haven, CT, USA., Swain MA; Paediatric Rehabilitation Service, Lady Cilento Children's Hospital, Bribane, QLD, Australia., Wallace J; Division of Child Neurology, Stanford University/Lucile Packard Children's Hospital, Palo Alto, CA, USA., Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, USA., Wang F; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Zhang H; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Merchant TE; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Robinson GW; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Conklin HM; Department of Psychology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105-2794, USA. heather.conklin@stjude.org.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2019 Jan; Vol. 141 (2), pp. 403-411. Date of Electronic Publication: 2018 Nov 22.
Autor:
Lifshitz, Hefziba1 (AUTHOR), Shnitzer-Meirovich, Shlomit2 (AUTHOR), Koslovsky, Meny3 (AUTHOR), Yozevitch, Roi4 (AUTHOR) yozevitch@gmail.com
Publikováno v:
Scientific Reports. 10/10/2024, Vol. 14 Issue 1, p1-14. 14p.
Autor:
Balice-Gordon R; Pfizer Worldwide Research and Development, Cambridge, MA., Honey GD; Pfizer Worldwide Research and Development, Cambridge, MA., Chatham C; Pfizer Worldwide Research and Development, Cambridge, MA., Arce E; Pfizer Worldwide Research and Development, Cambridge, MA., Duvvuri S; Pfizer Worldwide Research and Development, Cambridge, MA., Naylor MG; Pfizer Worldwide Research and Development, Cambridge, MA., Liu W; Pfizer Worldwide Research and Development, Cambridge, MA., Xie Z; Pfizer Worldwide Research and Development, Cambridge, MA., DeMartinis N; Pfizer Worldwide Research and Development, Cambridge, MA., Harel BT; Pfizer Worldwide Research and Development, Cambridge, MA., Braley GH; Pfizer Worldwide Research and Development, Cambridge, MA., Kozak R; Pfizer Worldwide Research and Development, Cambridge, MA., Park L; California Clinical Trials Medical Group/PAREXEL International, Glendale, CA., Gray DL; Pfizer Worldwide Research and Development, Cambridge, MA.
Publikováno v:
The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2020 May 27; Vol. 23 (5), pp. 287-299.
Autor:
Gilmour G; Translational Neuroscience, Eli Lilly & Co. Ltd., Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK. Electronic address: gilmour_gary@lilly.com., Porcelli S; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy., Bertaina-Anglade V; Biotrial, 7-9 rue Jean-Louis Bertrand, CS, 34246, 35042 Rennes Cedex, France., Arce E; Early Clinical Development, Worldwide Research and Development, Pfizer Inc., United States., Dukart J; F. Hoffmann-La Roche, pharma Research Early Development, Roche Innovation Centre Basel, Basel, Switzerland., Hayen A; P1vital Ltd., Wallingford, Oxfordshire, UK., Lobo A; Department of Medicine and Psychiatry, University of Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain., Lopez-Anton R; Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Psychology and Sociology Department, University of Zaragoza, Zaragoza, Spain., Merlo Pich E; CNS Therapeutic Area Unit, Takeda Development Centre Europe, London, England., Pemberton DJ; Janssen Research and Development, Beerse, Belgium., Havenith MN; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands., Glennon JC; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands., Harel BT; Early Clinical Development, Worldwide Research and Development, Pfizer Inc., United States., Dawson G; P1vital Ltd., Wallingford, Oxfordshire, UK., Marston H; Translational Neuroscience, Eli Lilly & Co. Ltd., Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK., Kozak R; Early Clinical Development, Worldwide Research and Development, Pfizer Inc., United States., Serretti A; Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.
Publikováno v:
Neuroscience and biobehavioral reviews [Neurosci Biobehav Rev] 2019 Feb; Vol. 97, pp. 47-69. Date of Electronic Publication: 2018 Nov 03.
Autor:
COLITA, EUGEN1, MATEESCU, VALENTIN OCTAVIAN2 denissagretaolaru@gmail.com, OLARU, DENISA-GRETA3, POPA-WAGNER, AUREL4
Publikováno v:
Current Health Sciences Journal. Apr-Jun2024, Vol. 50 Issue 2, p170-180. 11p.